Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic Hyperplasia
NCT02244242
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
493
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostatic Hyperplasia
Interventions
DRUG:
Tamsulosin hydrochloride
Sponsor
Boehringer Ingelheim